Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neonatal Intranasal Breast Milk, Impact on Brain Growth in Hypoxic-ischemic Encephalopathy Therapy (NEO-BRIGHT)

NCT06746532 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT06746532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06746532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neonatal Intranasal Breast Milk, Impact on Brain Growth in Hypoxic-ischemic Encephalopathy Therapy (NEO-BRIGHT)
Lead sponsor
Semmelweis University
Phase
Phase 1
Overall status
Recruiting
Start date
February 1, 2025
Completion date
December 31, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischaemic encephalopathy, neonatal encephalopathy, neonatal hypoxic ischemic encephalopathy, perinatal asphyxia